What does the Medicines Management team do?

The Medicines Management team is made up of Pharmacists, a Pharmacy Technician, a Dietitian and support and analytical staff who support health professionals in ensuring that patients get better, safer and more convenient care.

The team uses its wealth of knowledge and experience to provide unbiased information on medicines, supports practitioners to make the best use of medicines through advice and the development of local guides, and works with providers to ensure the right medicines are supplied at the right place.

The team provides support to health professionals directly and is unable to advise individual patients on their medicines. Your prescriber (e.g. GP) has access to your medical record and is in the best position to make prescribing decisions on your individual circumstances.

For more information, visit the “Who are the Medicines Management team?

Formulary and Prescribing Guidelines

Medicines Management


Please click on the heading to view formulary, shared care guidelines and pathways for each BNF chapter.

Coronavirus (COVID-19) - Patients

Coronavirus (COVID-19) - Clinicians

Vitamin D in Care Homes

Guidance for Care Homes on the use of Vitamin D supplements obtained by the DHSC


Coronavirus Position Statement

Position statement for prescribing for patients abroad during Coronavirus outbreak

Prescription management during COVID-19


Useful Covid-19 Resources

Information around medicines use in Covid-19 is changing rapidly. Stay on top of the most recent information produced by the government and the Royal Pharmaceutical Society, using the links below:





Please note that only registered users can download the below documents:

Covid-19 Vaccine

Covid-19 Vaccine Pharmacy Communications Reference Guide

Letter from Chief Medical Officers re UK Covid-19 Vaccination Programme

Optimising the Covid-19 vaccination programme for maximum short term impact

Green Book – Covid-19

Patient Group Direction for COVID-19 Vaccines

Standard operating procedure: COVID-19 local vaccination services deployment in community settings



Specialist Pharmacy Service (SPS) Covid-19 Pfizer-BioNTech vaccine resources

Patient Group Direction for COVID 19 mRNA vaccine BNT162b2 (Pfizer BioNTech)

National protocol for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech)



Specialist Pharmacy Service (SPS) - Resources for AstraZeneca Covid-19 vaccine

Patient Group Direction for COVID-19 Vaccine AstraZeneca

National protocol for COVID-19 Vaccine AstraZeneca

Position Statement AstraZeneca Vaccine Movement

Transporting AstraZeneca COVID-19 Vaccine from PCN Designated Sites to end user locations SOP


Covid-19 and professional advice

Security advice for pharmacies during COVID 19

COVID related professional advice

NHS Volunteer Responders information for health professionals


Covid-19 and services

Remote Outpatient Clinics - Medicines Supply

Responsibility for Prescribing - May 2020

Monitoring of shared care medicines during the COVID 19 pandemic

Access to Palliative Care Drugs for clinicans

Access to EOL Drugs in Primary Care during Covid-19

Essex arrangements for accessing End of Life Medicines and your role in the Re-Use of Medicines Scheme in Care Homes webinar

MSE Hospitals Group Anticoagulation Clinics


Covid-19 and medicines

Covid-19 - amber drugs

Ibuprofen and coronavirus (COVID 19)

Lithium and Covid-19 Guidance 

Rescue Pack Letter

Rescue packs for COPD and asthma for clinicians

Ramadan summary fasting recommendations - British Islamic Medical Association


Chapter 01 - Gastro-intestinal system

Chapter 02 - Cardiovascular system

Chapter 03 - Respiratory system

Chapter 04 - Nervous system

Chapter 05 - Infection

Chapter 06 - Endocrine system

Chapter 07 - Genito-urinary system

Chapter 08 - Malignant disease

Chapter 09 - Nutrition and blood

Chapter 10 - Musculoskeletal system

Chapter 11 - Eye

Chapter 12 - Ear, nose and oropharynx

Chapter 13 - Skin

End of Life formulary

Woundcare formulary

Traffic light list for prescribing

Position Statements

Coronavirus Position Statements

Position statement for prescribing for patients abroad during Coronavirus outbreak

Prescription management during COVID-19


Position Statements

7 Day Prescriptions

Alprostadil Cream


Cannabis products MSEMOC position statement

Camouflage Creams

Chronic Fatigue Syndrome (CFS) or myalgic encephalomyelitis (ME)

Compression Hosiery

Controlled Drugs on repeat template

Co-Proxamol is Not Supported for Acute or Chronic Pain


Dental preparations MSEMOC position statement

Doxazosin Modified Release

Dry eye syndrome management

Dupilumab for chronic rhinosinusitis with nasal polyps (NICE TA648) position statement

Emollients prescribing guidance

Eye Vitamins

Fentanyl immediate release preparations MSEMOC position statement

Fungal Nail Infection

Glucosamine for Osteoarthritis

Good Practice Guide for Paracetamol Prescribing

Hepatitis B

Herbal Treatments

Homeopathic Remedies

Infantile Colic

Ketamine for Chronic Pain

Length of Repeat Prescription Supply

Liothyronine MSEMOC position statement

Low Dose Naltrexone for the Treatment of Multiple Sclerosis

Medical Devices

Medicines that are Available for Purchase Over the Counter (Self Care)


Mexiletine (Namuscla) for treatment of myotonia

Molludab for Molluscum Contagiosum

Multivitamins post-bariatric surgery MSEMOC position statement

Omega 3 Fatty Acids

Oxycodone naloxone MSEMOC position statement

PDE5 Inhibitors for the Treatment of Erectile Dysfunction

Pigmanorm Cream for the Treatment of Melasma

Rifaximin Prescribing

Silicone Sheets and Gels

Sodium Hyaluronate for Osteoarthritis

Sunscreen Preparations

Therapeutic Clothing

Tramadol paracetamol MSEMOC position statement

Transfer of Prescriptions from Private to NHS

Travel Advice


Ulipristal Acetate (Esmya)

Vitamins and Minerals

Vitamin B complex

Vitamin D for supplementation insufficiency and maintenance doses MSEMOC position statement

Shared Care Guidelines

Prescribing Incentive Scheme

Prescribing Updates / Newsletters

Patient Information

Patient Letters

Practice Policies/Resources


National Medicine Shortages

NHSE Consultation